Formidable Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Formidable Asset Management’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-620	Closed	-$19K	–	520
2014 Q2	$19K	Hold	620	–	–	0.01%	289
2014 Q1	$16K	Hold	620	–	–	0.01%	276
2013 Q4	$14K	Hold	620	–	–	0.01%	302
2013 Q3	$13K	Buy	+620	New	+$12.8K	0.01%	271

Other funds holding IPXL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Formidable Asset Management's IPXL Position: Q3 2014 in Review

Formidable Asset Management sold out of Impax Laboratories, Inc. (IPXL) in Q3 2014, closing a stake of 620 shares — an estimated $19K sold.

Formidable Asset Management first reported a position in IPXL in Q3 2013 and held it in 4 quarters. The position peaked at $19K in Q2 2014. 162 funds tracked by Wall St. Rank hold IPXL as of Q3 2014.

Formidable Asset Management reported no remaining Impax Laboratories, Inc. position as of Q3 2014 after selling out during the quarter.
Formidable Asset Management sold 620 Impax Laboratories, Inc. shares in Q3 2014, an estimated $19K.
Formidable Asset Management first reported a position in Impax Laboratories, Inc. in Q3 2013 and held it in 4 quarters.
Formidable Asset Management's Impax Laboratories, Inc. position peaked at $19K in Q2 2014.
162 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2014.

Based on Formidable Asset Management's 13F filing for Q3 2014, filed 14 Nov 2014.